efficacy of tirzepatide Study: produces greater weight loss vs. other GLP-1s Tirzepatide as Adjunct to Insulin

Weight Loss Via Lifestyle Intervention Can Change Cardiac Biomarkers A secondary analysis of the LookAHEAD trial showed that lifestyle interventions targeting weight loss for type 2 diabetes patients led to a change in biomarkers associated with higher risk of cardiovascular disease and heart failure (HF)

The clinical literature supports this approach, as delayed escalation does not appear to compromise long-term weight loss outcomes

All these parameters may contribute to explain the lack of reproducibility between studies, and standardizing data records may help alleviate this issue in future studies

A Comprehensive Review of Fortification, Bioavailability, and Health Benefits of Folate

a comprehensive review